Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.03
MD's Cash-to-Debt is ranked lower than
91% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. MD: 0.03 )
Ranked among companies with meaningful Cash-to-Debt only.
MD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.35 Max: 312.43
Current: 0.03
0.01
312.43
Equity-to-Asset 0.51
MD's Equity-to-Asset is ranked higher than
56% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. MD: 0.51 )
Ranked among companies with meaningful Equity-to-Asset only.
MD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5  Med: 0.76 Max: 0.91
Current: 0.51
0.5
0.91
Debt-to-Equity 0.63
MD's Debt-to-Equity is ranked higher than
51% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. MD: 0.63 )
Ranked among companies with meaningful Debt-to-Equity only.
MD' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: 0.69
Current: 0.63
0
0.69
Debt-to-EBITDA 3.03
MD's Debt-to-EBITDA is ranked higher than
52% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. MD: 3.03 )
Ranked among companies with meaningful Debt-to-EBITDA only.
MD' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0  Med: 0.39 Max: 3.03
Current: 3.03
0
3.03
Interest Coverage 7.00
MD's Interest Coverage is ranked higher than
50% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. MD: 7.00 )
Ranked among companies with meaningful Interest Coverage only.
MD' s Interest Coverage Range Over the Past 10 Years
Min: 7  Med: 90.58 Max: 294.93
Current: 7
7
294.93
Piotroski F-Score: 5
Altman Z-Score: 2.50
Beneish M-Score: -2.52
WACC vs ROIC
3.12%
6.70%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.72
MD's Operating Margin % is ranked higher than
78% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. MD: 14.72 )
Ranked among companies with meaningful Operating Margin % only.
MD' s Operating Margin % Range Over the Past 10 Years
Min: 14.72  Med: 21.89 Max: 24.07
Current: 14.72
14.72
24.07
Net Margin % 7.77
MD's Net Margin % is ranked higher than
72% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. MD: 7.77 )
Ranked among companies with meaningful Net Margin % only.
MD' s Net Margin % Range Over the Past 10 Years
Min: 7.77  Med: 13.46 Max: 15.84
Current: 7.77
7.77
15.84
ROE % 9.41
MD's ROE % is ranked higher than
58% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. MD: 9.41 )
Ranked among companies with meaningful ROE % only.
MD' s ROE % Range Over the Past 10 Years
Min: 9.41  Med: 14.04 Max: 17.59
Current: 9.41
9.41
17.59
ROA % 4.82
MD's ROA % is ranked higher than
65% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. MD: 4.82 )
Ranked among companies with meaningful ROA % only.
MD' s ROA % Range Over the Past 10 Years
Min: 4.82  Med: 9.93 Max: 12.09
Current: 4.82
4.82
12.09
ROC (Joel Greenblatt) % 195.38
MD's ROC (Joel Greenblatt) % is ranked higher than
94% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. MD: 195.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 195.38  Med: 621.53 Max: 755.09
Current: 195.38
195.38
755.09
3-Year Revenue Growth Rate 17.00
MD's 3-Year Revenue Growth Rate is ranked higher than
80% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. MD: 17.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.9  Med: 16.95 Max: 72.8
Current: 17
6.9
72.8
3-Year EBITDA Growth Rate 13.50
MD's 3-Year EBITDA Growth Rate is ranked higher than
68% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. MD: 13.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 7.3  Med: 15.1 Max: 63.8
Current: 13.5
7.3
63.8
3-Year EPS without NRI Growth Rate 7.90
MD's 3-Year EPS without NRI Growth Rate is ranked higher than
52% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. MD: 7.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -20.2  Med: 14.05 Max: 74.5
Current: 7.9
-20.2
74.5
» MD's 30-Y Financials

Financials (Next Earnings Date: 2018-02-07)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

MD Guru Trades in Q4 2016

Joel Greenblatt 3,834 sh (New)
First Pacific Advisors 36,570 sh (+55.15%)
Vanguard Health Care Fund Sold Out
Columbia Wanger 792,941 sh (-6.44%)
Pioneer Investments 105,515 sh (-21.52%)
» More
Q1 2017

MD Guru Trades in Q1 2017

Joel Greenblatt 111,724 sh (+2814.03%)
First Pacific Advisors 36,570 sh (unchged)
Pioneer Investments Sold Out
Columbia Wanger 670,130 sh (-15.49%)
» More
Q2 2017

MD Guru Trades in Q2 2017

Steven Cohen 77,300 sh (New)
David Dreman 310 sh (New)
First Pacific Advisors 56,570 sh (+54.69%)
Joel Greenblatt Sold Out
Columbia Wanger Sold Out
» More
Q3 2017

MD Guru Trades in Q3 2017

Joel Greenblatt 59,951 sh (New)
Steven Cohen 132,700 sh (+71.67%)
First Pacific Advisors 56,570 sh (unchged)
David Dreman 310 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with MD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-09-30 New Buy0.04%$41.19 - $60.58 $ 51.758%59,951
David Dreman 2017-06-30 New Buy0.01%$53.95 - $69.38 $ 51.75-13%310
Joel Greenblatt 2017-06-30 Sold Out 0.1%$53.95 - $69.38 $ 51.75-13%0
Joel Greenblatt 2017-03-31 Add 2814.03%0.1%$65.25 - $72.03 $ 51.75-25%111,724
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:NYSE:HLS, NYSE:EVHC, BKK:BH, NYSE:CHE, HAM:CLS1, LSE:MDC, SZSE:300015, NAS:ACHC, ASX:HSO, JSE:LHC, XSGO:BANMEDICA, ASX:SHL, NSE:APOLLOHOSP, NYSE:SEM, NYSE:AMN, JSE:NTC, XTER:RHK, LSE:NMC, SAU:4002, NAS:LPNT » details
Traded in other countries:PDC.Germany, MD.Mexico,
Headquarter Location:USA
Mednax Inc is a provider of physician services including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric sub-specialty care.

Mednax Inc is a provider of physician services including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric sub-specialty care.

Top Ranked Articles about Mednax Inc

Market Trends Toward New Normal in Summit Materials, Advance Auto Parts, Palo Alto, Molson Coors Brewing, MEDNAX, and Sinclair Broadcast – Emerging Consolidated Expectations, Analyst Ratings
Stocks That Fell to Three-Year Lows in the Week of Sept. 15 Mednax Inc., OPKO Health Inc., Terra Nitrogen Co. and Dean Foods Co. have declined to their respective three-year lows
Mednax Inc. (NYSE:MD), OPKO Health Inc. (NASDAQ:OPK), Terra Nitrogen Co. LP (NYSE:TNH) and Dean Foods Co. (NYSE:DF) have declined to their three-year lows. Read more...
A Deep Analysis of 6 Five-Star Companies These companies have maintained a 5-star predictability rank for the past 5 years
Among U.S. companies, six have maintained a GuruFocus Business Predictability Rank of five stars year over year since June 2012: Jack Henry & Associates Inc. (NASDAQ:JKHY), Mednax Inc. (NYSE:MD), Mesa Laboratories Inc. (NASDAQ:MLAB), Rollins Inc. (NYSE:ROL), Tyler Technologies Inc. (NYSE:TYL) and World Acceptance Corp. (NASDAQ:WRLD). Read more...

Ratios

vs
industry
vs
history
PE Ratio 18.28
MD's PE Ratio is ranked higher than
84% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. MD: 18.28 )
Ranked among companies with meaningful PE Ratio only.
MD' s PE Ratio Range Over the Past 10 Years
Min: 6.95  Med: 17.69 Max: 25.04
Current: 18.28
6.95
25.04
Forward PE Ratio 15.20
MD's Forward PE Ratio is ranked lower than
99.99% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. MD: 15.20 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 18.28
MD's PE Ratio without NRI is ranked higher than
86% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. MD: 18.28 )
Ranked among companies with meaningful PE Ratio without NRI only.
MD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.01  Med: 17.81 Max: 25.52
Current: 18.28
8.01
25.52
Price-to-Owner-Earnings 12.35
MD's Price-to-Owner-Earnings is ranked higher than
88% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. MD: 12.35 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.51  Med: 15.56 Max: 23.37
Current: 12.35
5.51
23.37
PB Ratio 1.68
MD's PB Ratio is ranked higher than
76% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. MD: 1.68 )
Ranked among companies with meaningful PB Ratio only.
MD' s PB Ratio Range Over the Past 10 Years
Min: 1.23  Med: 2.26 Max: 3.59
Current: 1.68
1.23
3.59
PS Ratio 1.44
MD's PS Ratio is ranked higher than
63% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. MD: 1.44 )
Ranked among companies with meaningful PS Ratio only.
MD' s PS Ratio Range Over the Past 10 Years
Min: 1.12  Med: 2.22 Max: 3.84
Current: 1.44
1.12
3.84
Price-to-Free-Cash-Flow 11.92
MD's Price-to-Free-Cash-Flow is ranked higher than
85% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. MD: 11.92 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.34  Med: 14.43 Max: 20.82
Current: 11.92
6.34
20.82
Price-to-Operating-Cash-Flow 10.78
MD's Price-to-Operating-Cash-Flow is ranked higher than
73% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. MD: 10.78 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.83  Med: 13.47 Max: 19.76
Current: 10.78
5.83
19.76
EV-to-EBIT 13.18
MD's EV-to-EBIT is ranked higher than
87% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. MD: 13.18 )
Ranked among companies with meaningful EV-to-EBIT only.
MD' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.2  Med: 11.65 Max: 16.9
Current: 13.18
5.2
16.9
EV-to-EBITDA 11.00
MD's EV-to-EBITDA is ranked higher than
81% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. MD: 11.00 )
Ranked among companies with meaningful EV-to-EBITDA only.
MD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 10.65 Max: 15.4
Current: 11
5
15.4
EV-to-Revenue 1.97
MD's EV-to-Revenue is ranked higher than
60% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. MD: 1.97 )
Ranked among companies with meaningful EV-to-Revenue only.
MD' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.2  Med: 2.4 Max: 3.8
Current: 1.97
1.2
3.8
PEG Ratio 1.39
MD's PEG Ratio is ranked higher than
86% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. MD: 1.39 )
Ranked among companies with meaningful PEG Ratio only.
MD' s PEG Ratio Range Over the Past 10 Years
Min: 0.62  Med: 1.34 Max: 2.08
Current: 1.39
0.62
2.08
Shiller PE Ratio 18.69
MD's Shiller PE Ratio is ranked higher than
87% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. MD: 18.69 )
Ranked among companies with meaningful Shiller PE Ratio only.
MD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.06  Med: 25.76 Max: 42
Current: 18.69
13.06
42
Current Ratio 1.37
MD's Current Ratio is ranked higher than
58% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. MD: 1.37 )
Ranked among companies with meaningful Current Ratio only.
MD' s Current Ratio Range Over the Past 10 Years
Min: 0.77  Med: 1.39 Max: 11.34
Current: 1.37
0.77
11.34
Quick Ratio 1.37
MD's Quick Ratio is ranked higher than
61% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. MD: 1.37 )
Ranked among companies with meaningful Quick Ratio only.
MD' s Quick Ratio Range Over the Past 10 Years
Min: 0.77  Med: 1.39 Max: 11.34
Current: 1.37
0.77
11.34
Days Sales Outstanding 56.18
MD's Days Sales Outstanding is ranked lower than
67% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. MD: 56.18 )
Ranked among companies with meaningful Days Sales Outstanding only.
MD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.59  Med: 52.83 Max: 58.39
Current: 56.18
46.59
58.39
Days Payable 4.20
MD's Days Payable is ranked lower than
96% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. MD: 4.20 )
Ranked among companies with meaningful Days Payable only.
MD' s Days Payable Range Over the Past 10 Years
Min: 3.59  Med: 4.52 Max: 7.33
Current: 4.2
3.59
7.33

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.50
MD's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. MD: 2.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -17.4  Med: 0.45 Max: 19.4
Current: 2.5
-17.4
19.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.61
MD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
95% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. MD: 0.61 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.46  Med: 1.01 Max: 3.84
Current: 0.61
0.46
3.84
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.13
MD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
83% of the 36 Companies
in the Global Medical Care industry.

( Industry Median: 1.59 vs. MD: 1.13 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
MD' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.32  Med: 0.79 Max: 1.27
Current: 1.13
0.32
1.27
Price-to-Median-PS-Value 0.64
MD's Price-to-Median-PS-Value is ranked higher than
90% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. MD: 0.64 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22  Med: 1.06 Max: 3.71
Current: 0.64
0.22
3.71
Price-to-Peter-Lynch-Fair-Value 1.47
MD's Price-to-Peter-Lynch-Fair-Value is ranked higher than
80% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. MD: 1.47 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.09  Med: 1.18 Max: 2.05
Current: 1.47
0.09
2.05
Earnings Yield (Greenblatt) % 7.57
MD's Earnings Yield (Greenblatt) % is ranked higher than
90% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. MD: 7.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.9  Med: 8.6 Max: 19.1
Current: 7.57
5.9
19.1
Forward Rate of Return (Yacktman) % 19.91
MD's Forward Rate of Return (Yacktman) % is ranked higher than
84% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. MD: 19.91 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 14.7  Med: 19.4 Max: 25.5
Current: 19.91
14.7
25.5

More Statistics

Revenue (TTM) (Mil) $3,378.26
EPS (TTM) $ 2.83
Beta0.12
Short Percentage of Float4.68%
52-Week Range $40.56 - 72.13
Shares Outstanding (Mil)93.66

Analyst Estimate

Dec17 Dec18
Revenue (Mil $)
EPS ($) 3.31 3.46
EPS without NRI ($) 3.31 3.46
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}